Selection of a subpopulation with fewer DNA topoisomerase Ila gene copies in a doxorubicin-resistant cell line panel
1996

Fewer DNA Topoisomerase Ila Gene Copies in Doxorubicin-Resistant Cells

publication Evidence: moderate

Author Information

Author(s): S Withoff, WN Keith, AJ Knol, JC Coutts, SF Hoare, NH Mulder, EGE de Vries

Primary Institution: University Hospital Groningen

Hypothesis

Does the decrease in DNA topoisomerase Ila gene copies contribute to mRNA decrease in doxorubicin-resistant cell lines?

Conclusion

The study concludes that the decrease in TopoIla gene copy number is associated with reduced TopoIla mRNA and protein levels in doxorubicin-resistant cell lines.

Supporting Evidence

  • The study found that as resistance to doxorubicin increased, the number of TopoIla gene copies decreased.
  • Fluorescence in situ hybridization showed that most cells in the resistant line had only two copies of the TopoIla gene.
  • Previous studies indicated that reduced TopoIla levels are linked to drug resistance in cancer cells.

Takeaway

Some cancer cells become resistant to a drug called doxorubicin by having fewer copies of a gene that helps fight the drug, making it less effective.

Methodology

The study used fluorescence in situ hybridization and mRNA slot-blotting to analyze gene copy numbers and mRNA levels in various doxorubicin-resistant cell lines.

Limitations

The sensitivity of Southern blotting may not be sufficient to detect small changes in gene copy numbers.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication